Suppressed cGAS–STING DNA Sensing Drives Immune Evasion in Anaplastic Thyroid Cancer
Thyroid® · 2026
DOI: 10.1177/10507256261481666 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thyroid®, 2026. Verfasst von Xu-Guang Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Hauptthemen laut MEDLINE: Thyroid Carcinoma, Anaplastic, Nucleotidyltransferases, Membrane Proteins, Thyroid Neoplasms. Die Arbeit nennt 43 Literaturangaben. Gefördert von: NIH HHS, Basic Research Laboratory.
Abstract (Originalsprache)
Background
Anaplastic thyroid cancer (ATC) is a highly lethal malignancy with poor survival and limited therapeutic options. The mechanisms driving immune evasion in ATC remain poorly understood. The cyclic GMP–AMP synthase–stimulator of interferon genes (cGAS–STING) pathway is a key mediator of innate immune sensing and antitumor immunity.
Methods
We investigated the role of cGAS–STING signaling in ATC using three complementary models (i) a genetically engineered mouse model harboring triple mutations in Thrb1 , Trp53 , and Pten (RU3 model); (ii) an orthotopic tumor model derived from Trp53 - and Braf -mutant ATC cells; and (iii) subcutaneous tumor models of Ifnb1 - or Trp53 -expressing ATC cells. Tumor immune microenvironment alterations were assessed using comprehensive molecular approaches, including single-cell RNA sequencing.
Results
The models demonstrated marked suppression of cGAS–STING signaling during ATC progression. This suppression was associated with impaired antitumor immunity, characterized by reduced CD8 + T cell infiltration and diminished type I interferon (IFN-I) responses. Restoration of IFNβ1 signaling in ATC cells significantly enhanced CD8 + T cell recruitment and inhibited tumor growth in vivo . These findings indicate that immune evasion in ATC is driven by decreased IFNβ1 production rather than resistance to its downstream effects. Mechanistically, p53 was found to sustain cGAS–STING–IFNβ1-mediated antitumor immunity, and its loss contributed to reduced IFNβ1 expression and immune escape.
Conclusions
Impaired DNA sensing via suppression of the cGAS–STING–IFNβ1 axis promotes immune evasion in ATC. Therapeutic strategies aimed at restoring this pathway may enhance antitumor immunity and represent a promising approach for treating this aggressive disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
- CCR Collaborative Bioinformatics Resource, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
- Advanced Biomedical Computational Science, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
- Endocrine Surgery Section, Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
ORCID-Profile: Manju Acharya, Nathan Wong, Sheue-Yann Cheng
Förderung
- NIH HHS
- Basic Research Laboratory
Zitieren
APA
Zhu, X. G., Acharya, M., Hwang, E., Wong, N., Nilubol, N., & Cheng, S. Y. (2026). Suppressed cGAS–STING DNA Sensing Drives Immune Evasion in Anaplastic Thyroid Cancer. Thyroid®. https://doi.org/10.1177/10507256261481666
Vancouver
Zhu XG, Acharya M, Hwang E, Wong N, Nilubol N, Cheng SY. Suppressed cGAS–STING DNA Sensing Drives Immune Evasion in Anaplastic Thyroid Cancer. Thyroid®. 2026. doi:10.1177/10507256261481666
BibTeX
@article{Zhu2026,
author = {Zhu, Xu-Guang and Acharya, Manju and Hwang, Eunmi and Wong, Nathan and Nilubol, Naris and Cheng, Sheue-Yann},
title = {Suppressed cGAS–STING DNA Sensing Drives Immune Evasion in Anaplastic Thyroid Cancer},
journal = {Thyroid®},
year = {2026},
doi = {10.1177/10507256261481666}
}
EUVIMED